Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03567486
Other study ID # DCT_2017_18
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 18, 2017
Est. completion date January 2024

Study information

Verified date December 2023
Source Fondation Ophtalmologique Adolphe de Rothschild
Contact Dorian Chauvet
Phone +33 148036915
Email dchauvet@for.paris
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Paraoptic tumors - including mostly sellar meningiomas, pituitary gland adenomas and craniopharyngiomas - classically affect the visual function. Some preoperative factors, determined on retrospective studies, are known to constitute bad prognostic factors, such as duration of symptoms and retinal nerve fiber layer thinning on OCT. We propose to perform a single center prospective study in which detailed preoperative ophthalmological and radiological criteria will be collected before surgery. Intraoperative information will be noted as well. All these data will be statistically examined regarding the postoperative visual recovery at 3, 6 and 12 months


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date January 2024
Est. primary completion date December 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - tuberculum sellae meningioma surgical indication Exclusion Criteria: - surgical contra indication MRI contra indication optical disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Fondation Ophtalmologique Adolphe de Rothschild Paris

Sponsors (1)

Lead Sponsor Collaborator
Fondation Ophtalmologique Adolphe de Rothschild

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary variation of Visual field between before surgery and 6 months postoperatively